A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

SCHIZOPHRENIA 1 (Disorder) · Schizoaffecitve Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

New York State Psychiatric Institute, New York, New York, United States

Study leads

Joshua T Kantrowitz, MD
Principal Investigator
New York State Psychiatric Institute
Ragy Girgis, MD
Principal Investigator
New York State Psychiatric Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Schizophrenia

Abroad (travel likely)RecruitingPHASE1

Los Alamitos, United States · Hollywood, United States

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

Alcohol Use Disorder · Alcohol Abuse/Dependence · Alcohol Dependence

Abroad (travel likely)RecruitingPHASE2

Aalborg, Denmark · Frederiksberg, Denmark

TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis

Psychosis · Schizo Affective Disorder · SCHIZOPHRENIA 1 (Disorder)

Abroad (travel likely)Recruiting

Copenhagen, Denmark · Roskilde, Denmark

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

Schizophrenia

Abroad (travel likely)Recruiting

Houston, United States